Dicetyl phosphate-
tetraethylenepentamine (DCP-
TEPA) conjugate was newly synthesized and formed into
liposomes for efficient
siRNA delivery. Formulation of DCP-
TEPA-based polycation
liposomes (
TEPA-PCL) complexed with
siRNA was examined by performing knockdown experiments using stable EGFP-transfected HT1080 human
fibrosarcoma cells and
siRNA for GFP. An adequate amount of DCP-
TEPA in
TEPA-PCL and N/P ratio of
TEPA-PCL/
siRNA complexes were determined based on the knockdown efficiency. Then, the biodistribution of
TEPA-PCL modified with poly(
ethylene glycol) (PEG) was examined in BALB/c mice. As a result,
TEPA-PCL modified with PEG6000 avoided reticuloendothelial system uptake and showed long circulation in the bloodstream. On the other hand, PEGylation of
TEPA-PCL/
siRNA complexes caused dissociation of a portion of the
siRNA from the
liposomes. However, we found that the use of
cholesterol-conjugated
siRNA improved the interaction between
TEPA-PCL and
siRNA, which allowed PEGylation of
TEPA-PCL/
siRNA complexes without
siRNA dissociation. In addition,
TEPA-PCL complexed with
cholesterol-conjugated
siRNA showed potent knockdown efficiency in stable
luciferase-transfected B16-F10 murine
melanoma cells. Finally, the biodistribution of
cholesterol-conjugated
siRNA formulated in PEGylated
TEPA-PCL was examined by performing near-infrared fluorescence imaging in Colon26 NL-17 murine
carcinoma-bearing mice. Our results showed that
tumor targeting with
siRNA via systemic administration was achieved by using PEGylated
TEPA-PCL combined with active targeting with
Ala-Pro-Arg-Pro-Gly, a
peptide used for targeting angiogenic endothelium.